Genome, Proteome and Tissue Microarray in Childhood Acute Leukemia
Trial ID or NCT#
Status
Purpose
We will study gene and protein expression in leukemia cells of children diagnosed with acute leukemia. We hope to identify genes or proteins which can help us grade leukemia at diagnosis in order to: (a) develop better means of diagnosis and (b) more accurately choose the best therapy for each patient.
Official Title
Genome, Proteome and Tissue Microarray in Childhood Acute Leukemia
Eligibility Criteria
- 1. All children who present at Packard hospital with a new diagnosis or relapse of acute leukemia will be eligible. There is no bias in regards to age range, gender or ethnic background.
- 2. Signed informed consent
Investigator(s)
Contact us to find out if this trial is right for you.
Contact
Norman J Lacayo
650-723-5535
View on ClinicalTrials.gov